Study of Antioxidants on MRI Detectable Early Stage Prostate Cancer Among Men on Active Surveillance
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether antioxidants (vitamin E, selenium and
lycopene)can change(reduce)prostate tumor size or blood flow to the prostate as determined by
MRI imaging among men on Active Surveillance.
Phase:
Phase 2
Details
Lead Sponsor:
University Health Network, Toronto
Collaborator:
The Prostate Cancer Research Foundation of Canada
Treatments:
alpha-Tocopherol Antioxidants Cholecalciferol Ergocalciferols Lycopene Selenium Tocopherols Tocotrienols Vitamin D Vitamin E Vitamins